Towards Healthcare

News

Your Daily Gateway to Essential News in Healthcare, Science, Technology and Business Worldwide

RareSight and PolyActiva in a mission to advance treatments for Rare Pediatric Retinal Diseases
10 November 2025

RareSight and PolyActiva in a mission to advance treatments for Rare Pediatric Retinal Diseases

Announcement The alliances have evolved and faced the challenges together to build a healthy tomorrow. The latest partnership has been introduced in the vast healthcare market. The PolyActiva, a clinical-level biopharmaceutical company standing in a well-defined position with the novel drug deliver...

Kardigan's acquisition strategy to build a Heart Health Company with robust data and platform
10 November 2025

Kardigan's acquisition strategy to build a Heart Health Company with robust data and platform

Announcement The Kardigan, the leading heart health company advancing cardiovascular (CV) drug development, has acquired Prolaio, a clinical-fuelled company modernising care and research with real-world patient insights and data. Additionally, Prolaio’s FDA-approved patient monitoring softwa...

Precision Biologics proves efficacy against various human cancer types
10 November 2025

Precision Biologics proves efficacy against various human cancer types

Announcement Precision Biologics, Inc. declared in vivo and in vitro efficacy of its novel tumor-specific ADC (PB-vcMMAE-5) in competition against human carcinomas reacting with truncated core 2 O-glycans. The current data for various human cancer types, précising truncated core 2 O-glycans...

OrsoBio’s new data to highlight in ObesityWeek® 2025
07 November 2025

OrsoBio’s new data to highlight in ObesityWeek® 2025

Announcement OrsoBio, a leading clinical-level biopharmaceutical company working towards the development of related metabolic disorders and obesity treatments, have showcased the presentation of new preclinical and clinical data at ObesityWeek® 2025 held in Atlanta, Ga, on November 4-7. The com...

Avant Technologies, in consortium to shape the future of Cell-Based Diabetes Treatment
07 November 2025

Avant Technologies, in consortium to shape the future of Cell-Based Diabetes Treatment

Announcement Avant Technologies Inc., a leading Nevada-based corporation and SGAustria Pte. Ltd., a known Singapore biotechnology company, have formed a groundbreaking alliance and signed a license agreement to bring revolutionary positive changes and advancement in diabetes treatment via encapsul...

ADLM’s new guidance to enhance patient care, taking blood thinners
07 November 2025

ADLM’s new guidance to enhance patient care, taking blood thinners

Announcement The Association for Diagnostics and Laboratory Medicine (ADLM) has introduced a smart expert-proven guidance on coagulation testing in patients on blood thinners who have a high chance of disrupting these tests. By supporting laboratory medicine professionals and clinicians to map the...

SimplyTest and Evexia to enter an expansion purpose-built partnership
07 November 2025

SimplyTest and Evexia to enter an expansion purpose-built partnership

Announcement SimplyTest® has signed a partnership agreement with Evexia Diagnostics, a leading provider of diagnostic laboratory services for unified and functional medicine. With this partnership deal, the two SimplyTests’ focused examinations, 4-point cortisol and SimplyTest PERIO, are...

The UPS’s acquisition of billions, a new business strategy
06 November 2025

The UPS’s acquisition of billions, a new business strategy

Announcement The United Parcel Service (UPS), a leading logistics, supply chain and shipping management company, a known American multinational operating across 200 countries and territories, has acquired Andlauer Healthcare Group Inc. (AHG), a popular North American supply chain management compan...

Evaxion’s new AI-framed precision cancer vaccine candidate to promote healthtech
06 November 2025

Evaxion’s new AI-framed precision cancer vaccine candidate to promote healthtech

Announcement Evaxion A/S, a leading clinical-level TechBio company, expert in establishing AI-Immunology™-powered vaccines, extended its R&D portfolio with EVX-04, an AI-framed precision cancer vaccine candidate. The company will carry out clinical development of EVX-04, recently been inv...

United Therapeutics’ transplantation success in its extensive trial
06 November 2025

United Therapeutics’ transplantation success in its extensive trial

Announcement The leading United Therapeutics Corporation has completed its first clinical xenotransplantation in its EXPAND study, using UKidney™ in patients with end-stage renal disease (ESRD). At NYU Langone Health, this successful transplant procedure was performed. The UKidney is an inves...